Darktrace Share Discussion Threads

[apotheki] 19/4/2024 15:07

Darktrace boosted by BofA double-upgrade to 'buy'

Shares in Darktrace advanced, bucking the weaker market trend, as Bank of America double-upgraded its rating to 'buy'

[foreverbull] 19/4/2024 09:16

Wuh...what? It may have skipped your attention but DT have won various awards which includes Th Cyber AI Product of the year, AI and Machine Learning Award. It has unbelievably 9000+ customer with more than 2000 employees, 175 patents, started from scratchy and now recurring revenue of more than $0.5billions expected to rise to $0.7billion. It is a bit disappointing that novices like you don't read the financial and other information properly.

[deputy303] 18/4/2024 19:44

What’s up millennial have you not closed your short

[apotheki] 17/4/2024 09:45

Great company growing fast

Target 1000p

[millennialinvestor] 17/4/2024 09:42

Bunch of scammers selling fancy graphics on a network monitoring tool that you can get open source for free.

Target 40p.

[halfpenny] 17/4/2024 08:40

Interest Rated Remain Higher for longer Debt Increases.

Target 400p ....

[timmy11] 12/4/2024 19:23

Broker Recommendations for Darktrace (DARK)
Date Broker Recommendation Old Target New Target Rating Type
12-Apr-24 Jefferies Buy - 890.00 Reiteration

[millennialinvestor] 11/4/2024 15:08

Darktrace? More like retrace.

[someuwin] 11/4/2024 12:21

...And of course, if DARK is trading 60% below US peer groups. That means DARK has to increase 150% to catch up.

[someuwin] 11/4/2024 12:11

Analysts at Berenberg raised their target price on software and services firm Darktrace from 600.0p to 630.0p on Thursday after the group's third-quarter results earlier this morning demonstrated a continuation of "strong momentum" seen in Q2.

Berenberg noted that annualised recurring revenues had grown 23.5% year-on-year to $731.1m, with $29.0m of net annual recurring revenues added in the quarter – up 6.2% year-on-year.

"We think that this is particularly significant within the context of negative yoy changes in net ARR added in Q1 (-22%) and Q2 (-4%)," said Berenberg, which has a 'buy' rating on the stock.

The German bank added that the company also upgraded its growth and margin outlook for the third time in three months, leading the analysts to increase its ARR, revenue and adjusted underlying earnings forecasts in response.

"In our view, Darktrace remains poised to outperform, given: a) its ongoing potential to exceed growth and margin expectations; b) that it has sufficient growth and operating leverage to drive a c30% FY23- FY26 CAGR in free cash flow per share; and c) the fact that it warrants a multiple rerating – at 4.4x CY24 EV/sales, it trades at a c60% CY24 EV/sales discount to US peers," said Berenberg.

"Darktrace trades on 4.4x CY24 EV/sales, c60% below our US peer group, despite similar expected sales growth and higher expected margins."

[bartyb] 11/4/2024 11:51

Berenberg raises Darktrace price target to 630 (600) pence - 'buy'
In today's Broker ratings

[2cmb] 11/4/2024 11:43

DP' the shorts did a lot of damage to this share. It will recover even if no T/O.
The shareprice fell of a cliff but will recover over time it climbs back by steps. Takes time but I am in no rush. :-)

ATB.

[buoycat] 11/4/2024 08:56

No wonder the UK stock market is so poorly valued. The best we can hope for is a bid from a foreign buyer?

[villarich] 11/4/2024 08:13

DaRkTrAcE? mOrE lIkE rEtRaCe LoLzzzzzzzzAnother great update. Once again proving the doubters wrong.

[donald pond] 11/4/2024 08:11

Amazing lack of investor interest given this is about the only tech stock on the LSE

[zam1] 11/4/2024 07:51

Dark expect higher earnings could push it upwards

[beergut] 11/4/2024 07:23

Are we happy ?

[donald pond] 11/4/2024 07:23

Nice upgrade. Surely a bid comes soon

[apotheki] 28/3/2024 13:21

So just not relevant!

[apotheki] 28/3/2024 13:16

Apart from him of course who really cares?

[bbmsionlypostafter mk2] 28/3/2024 11:34

How's Mike Lynch's trial going?

[apotheki] 28/3/2024 11:15

Who let the TROLLs out? Who? Who? / Who let the TROLLs out? Who? Who?

[halfpenny] 28/3/2024 06:51

Chartist Analysts Target 300p support or even less to be tested.

Show us the Money??
Too Risky at these levels is Funding Capital required!!

Dark Days Ahead...Too Risky...

Chart shows Lows to come again as History shows Rapid Falls after Major Investor Sells Stake!!